Patients Sponsored 12 Questions with Kim Innes Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
Patients Why Britain's blood tests are only as reliable as the journe... What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
Patients Moving beyond intent: Building more diverse clinical trials Improving representation is not simply about increasing awareness or setting enrolment targets. It requires identifying and removing the barriers.
Patients Progress with England’s Single National Formulary after a ye... Leela Barham digs deeper into the progress update from NHS England in July 2026.
Patients Moving from patient centricity to patient partnership The desire for patients to be active partners in research challenges how organisations approach patient engagement.
Patients End-of-life choice means little without end-of-life support A strong end-of-life care system does not wait until the final days to step in.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
